GAVI Money Pit, FDA and Vaccine Companies Conceal Fatal Myocarditis Risk with COVID-19 Vaccines

Please enjoy this rapid update from Stinchfield Tonight June 26, 2025. After covering recent news on the Global Vaccine Alliance, Dr. McCullough makes the argument that even one case of fatal vaccine myocarditis is cause for a boxed label on a product. After hundreds of adjudicated cases in the peer-reviewed literature, both Pfizer and Moderna have been long overdue on this critical warning. It is up to the manufacturers to update their package inserts with important safety information. Recent label changes amount to window-dressing, implying a cover-up. McCullough said a federal probe and special prosecutor are warranted. Courtesy Real America's Voice June 26, 2025.

Citations:

Mead, M. N., Seneff, S., Wolfinger, R., Rose, J., Denhaerynck, K., Kirsch, S., & McCullough, P. A. (2024). COVID-19 Modified mRNA "Vaccines" Part 1: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex. International Journal of Vaccine Theory, Practice, and Research, 3(2), 1112–1178.

Mead, M. N., Seneff, S., Rose, J., Wolfinger, R., Hulscher, N., & McCullough, P. A. (2024). COVID-19 Modified mRNA "Vaccines": Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2. International Journal of Vaccine Theory, Practice, and Research, 3(2), 1246–1315.